RESPIRATORY vaccine guidance has gained unified support from four leading medical societies ahead of the 2026–2027 virus season.
The American Thoracic Society (ATS), American Academy of Allergy, Asthma & Immunology (AAAAI), American College of Chest Physicians (CHEST), and Society of Critical Care Medicine (SCCM) have unanimously endorsed recommendations for influenza, respiratory syncytial virus (RSV), and COVID-19 vaccination in adults and children.
The joint endorsement aims to provide consistent, evidence-based recommendations for clinicians managing patients with respiratory conditions, particularly those vulnerable to severe viral illness.
The multisociety Vaccine Guidance Review Panel was established following changes to the Centers for Disease Control and Prevention (CDC) and Advisory Committee on Immunization Practices (ACIP) processes in 2025.
According to the participating organizations, these changes resulted in potentially harmful modifications to vaccination schedules, raising concerns about consistency with established scientific evidence.
In response, the panel reviewed and endorsed the vaccine recommendation development processes and resulting guidance from four medical organizations: the American Academy of Pediatrics, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, and Infectious Diseases Society of America.
The panel also reached consensus on guidance aligned with ACIP recommendations issued before June 2025, reinforcing a coordinated approach to respiratory disease prevention.
The endorsement covers influenza, RSV, and COVID-19 vaccination recommendations across pediatric and adult populations.
A particular priority is ensuring that clinicians caring for patients with chronic or acute respiratory diseases have access to consistent vaccination guidance as seasonal respiratory virus circulation increases.
The organizations emphasized that preventive vaccination remains an essential component of protecting patients against severe respiratory illness.
Michelle Ng Gong, ATS President, highlighted the importance of clear recommendations for clinicians treating patients with serious lung disease, particularly during periods of uncertainty surrounding national vaccination policies.
For physicians, the endorsement establishes a unified professional position on respiratory vaccination and provides a framework for discussing preventive care with patients.
The participating societies emphasized that consistent recommendations can strengthen clinical decision-making, support patient education, and promote equitable access to preventive healthcare.
The collaboration also reinforces the importance of integrating vaccination into routine respiratory and critical care, particularly for populations at greatest risk of severe illness.
By aligning recommendations across specialties, the panel aims to reduce confusion and strengthen confidence in evidence-based vaccination ahead of the respiratory virus season.
Reference
American College of Chest Physicians (CHEST). Multisociety Panel Endorses Vaccine Recommendations to Protect Respiratory Health. November 5, 2026. Available at: https://www.chestnet.org/newsroom/chest-news/2026/11/multisociety-panel-endorses-vaccine-recommendations-to-protect-respiratory-health. Last accessed: November 9, 2026.
Featured Image: AntonioDiaz on Adobe Stock.
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
